Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality

G. Lip | S. Perrella | G. d’Ettorre | C. Miele | F. Cipollone | F. Violi | M. Mancone | C. D’agostino | P. Guariglia | G. Lip | M. Rocco | F. Pacini | Valentina Perri | M. Lichtner | C. Mastroianni | F. Pugliese | M. Pirro | R. Cangemi | C. Ricci | M. de Angelis | A. Oliva | L. Celani | Letizia Santinelli | G. Ceccarelli | D. D’Ardes | L. Titi | Francesco De Lazzaro | G. Giordano | G. Russo | M. Ciardi | Gabriella De Girolamo | P. Vassalini | Claudia Pinacchio | C. Manganelli | P. Pignatelli | F. Ruberto | F. Alessandri | D. Ferro | Francesco Francesco Franco Alida Daniela Francesco Daniela C Pugliese Alessandri Ruberto Albante Aur | A. Albante | D. Auricchio | Daniela M. De Lauri | Carmela Di Santo | S. Ianni | E. Magnanimi | Fabiola Ratini | A. Sabani | P. Vaccaro | K. Bruno | P. Celli | Stella Consolo | C. Croce | L. Giannetti | S. Martelli | T. Messina | Elisa Pattelli | M. Portieri | N. Almenrader | R. Arzilla | E. Delia | C. Di Giovanni | A. Laderchi | Carlotta Macrì | M. Marandola | Giada Nardecchia | M. Pacilli | Fabio Silvio Mario Araimo Morselli | C. Imperiale | P. Tordiglione | C. Ajassa | V. Trinchieri | L. Antonelli | Rosaria Maria Cuomo | M. Carnevalini | C. Mastropietro | G. Iaiani | I. Mezzaroma | M. Falciano | A. Brogi | N. Cavallari | Marco Rivano Capparuccia | A. Massetti | C. Fimiani | M. Santori | Alessandro Bianchi | C. Franchi | Maurizio De Angelis | S. Sereno | C. Furlan | G. D. De Sanctis | F. Paoletti | P. Pasculli | F. Cogliati Dezza | F. Cancelli | G. Savelloni | S. Valeri | G. Siccardi | Federica Alessi | G. Recchia | M. Ridolfi | F. Romani | R. Aronica | V. Filippi | Mauro Vera | Lorenzo Volpicelli | Matteo Candy | Rugova Alban | S. Di Bari | Francesca Gavaruzzi | E. Casali | Maria Serena Carli | A. Zingaropoli | M. De Angelis | P. Nijhawan | Pietro Giuseppe Innocenti | F. Mengoni | Alessandro Bianchi | C. Ricci | Francesco Pugliese | Serena Perrella | C. D'Agostino | Daniela M. De Lauri | Carmela Di Santo | Massimo Mancone | Carlotta Macrì | Giada Nardecchia | Rosaria Maria Cuomo | L. Volpicelli | F. Gavaruzzi | Maria Serena Carli | Pietro Giuseppe Innocenti | Martina Carnevalini | Alessandra Oliva | Francesco Alessandri | C. Mastroianni | S. Perrella | Francesco Pugliese | M. Carli | P. G. Innocenti

[1]  G. d’Ettorre,et al.  Nox2 activation in Covid-19 , 2020, Redox Biology.

[2]  N. Mackman,et al.  Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[3]  F. Cipollone,et al.  IS ALBUMIN PREDICTOR OF MORTALITY IN COVID-19 ? , 2020, Antioxidants & redox signaling.

[4]  G. d’Ettorre,et al.  Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19. , 2020, Circulation research.

[5]  F. Violi,et al.  SARS-CoV-2 and myocardial injury: a role for Nox2? , 2020, Internal and Emergency Medicine.

[6]  M. Aepfelbacher,et al.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[7]  F. Violi,et al.  Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge , 2020, Thrombosis and Haemostasis.

[8]  Yutao Guo,et al.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.

[9]  B. Song,et al.  Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review , 2020, European Radiology.

[10]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[11]  B. Nordestgaard,et al.  Plasma Albumin and Incident Cardiovascular Disease , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[12]  A. Farcomeni,et al.  Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis , 2019, Internal and Emergency Medicine.

[13]  F. Violi,et al.  Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia. , 2019, The American journal of cardiology.

[14]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[15]  Robert A. Campbell,et al.  TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. , 2019, Blood.

[16]  G. Corazza,et al.  Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis , 2019, Hepatology communications.

[17]  O. Barbarash,et al.  FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION , 2018, Fundamental and Clinical Medicine.

[18]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[19]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[20]  F. Violi,et al.  Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly. , 2017, Antioxidants & redox signaling.

[21]  Marco Falcone,et al.  Cardiovascular Complications and Short-term Mortality Risk in Community-Acquired Pneumonia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  F. Violi,et al.  Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia. , 2016, The Journal of infection.

[23]  Marc P. Bonaca,et al.  Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis–Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50) , 2016, Circulation.

[24]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[25]  F. Violi,et al.  Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events. , 2015, The American journal of cardiology.

[26]  A. Farcomeni,et al.  Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia , 2015, Thorax.

[27]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[28]  A. Hoes,et al.  [Guidelines on cardiovascular disease prevention in clinical practice]. , 2005, Revue medicale de Liege.

[29]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[30]  G. FitzGerald,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients , 1999 .

[31]  A. U. Rickel,et al.  Guidelines for Prevention, I , 1998 .